BCSCDB: Biomarkers of Cancer Stem Cells Database
Number of entries related to SW1116 cell line is 118
| GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DPP4 | 3009 | LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | FACs and Western Blotting followed by IF staining and SFA | NA | 0.64 | 0.0085 | 31285270 |
| EPCAM | 11529 | LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | FACs and Western Blotting followed by IF staining and SFA | NA | 0.64 | 0.211 | 31285270 |
| LGR5 | 4504 | LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | FACs and Western Blotting followed by IF staining and SFA | NA | 0.64 | 0.0753 | 31285270 |
| CAPZA1 | 1488 | HTM/LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Proteomics and Western Blotting | Up | 0.36 | 0.0011 | 21455326 |
| CLIC1 | 2062 | HTM/LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Proteomics and Western Blotting | Up | 0.36 | 0.0042 | 21455326 |
| EEF1D | 3211 | HTM/LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Proteomics and Western Blotting | Up | 0.36 | 0.0042 | 21455326 |
| GAPDH | 4141 | HTM/LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Proteomics and Western Blotting | Up | 0.36 | 0.0053 | 21455326 |
| SFN | 10773 | HTM/LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Proteomics and Western Blotting | Up | 0.36 | 0.0053 | 21455326 |
| TUBB | 20778 | HTM/LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Proteomics and Western Blotting | Up | 0.36 | 0.0032 | 21455326 |
| UFD1 | 12520 | HTM/LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Proteomics and Western Blotting | Up | 0.36 | 0.0011 | 21455326 |
| CD44 | 1681 | LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | FACs followed by IF staining and SFA | NA | 0.36 | 1 | 31285270 |
| CD44 | 1681 | LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | FACs followed by RT-PCR and SFA | NA | 0.36 | 1 | 23674142 |
| CD44 | 1681 | LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | FACs | NA | 0.36 | 1 | 32617772 |
| CD44 | 1681 | LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | FACs followed by SFA | NA | 0.36 | 1 | 23007737 |
| CD44 | 1681 | LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | FACs followed by SFA | NA | 0.36 | 1 | 23007737 |
| ITGB1 | 6153 | LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by FACs and RT-PCR | NA | 0.32 | 0.018 | 21455326 |
| PROM1 | 9454 | LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | FACs followed by RT-PCR and SFA | NA | 0.32 | 0.7582 | 23674142 |
| PROM1 | 9454 | LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by FACs and RT-PCR | NA | 0.32 | 0.7582 | 21455326 |
| PROM1 | 9454 | LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | FACs | NA | 0.32 | 0.7582 | 32617772 |
| PROM1 | 9454 | LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | FACs followed by SFA | NA | 0.32 | 0.7582 | 23007737 |
| PROM1 | 9454 | LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | FACs followed by SFA | NA | 0.32 | 0.7582 | 23007737 |
| PROM1 | 9454 | LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | FACs followed by SFA | NA | 0.32 | 0.7582 | 31285270 |
| CCND1 | 1582 | LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | Western Blotting | NA | 0.28 | 0.0201 | 23674142 |
| E2F3 | 3115 | LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | Western Blotting | NA | 0.28 | 0.0011 | 23674142 |
| MIR194-1 | 31564 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.24 | 0.0021 | 23007737 |
| MIR29B1 | 31619 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.24 | 0.0064 | 23007737 |
| MIR1231 | 33921 | HTM/LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0011 | 22180714 |
| MIR192 | 31562 | HTM/LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics and qPCR | Up | 0.24 | 0.0021 | 22180714 |
| MIR194-1 | 31564 | HTM/LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics and qPCR | Up | 0.24 | 0.0021 | 22180714 |
| MIR215 | 31592 | HTM/LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics and qPCR | Up | 0.24 | 0.0021 | 22180714 |
| MIR29B1 | 31619 | HTM/LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics and qPCR | Up | 0.24 | 0.0064 | 22180714 |
| MIR32 | 31631 | HTM/LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics and qPCR | Up | 0.24 | 0.0042 | 22180714 |
| MIR33A | 31634 | HTM/LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics and qPCR | Up | 0.24 | 0.0021 | 22180714 |
| MIR93 | 31645 | HTM/LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics and qRT-PCR | Down | 0.24 | 0.0032 | 22180714 |
| MIR302C | 31764 | HTM/LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | FACs for CSC marker followed by qRT-PCR | Down | 0.2 | 0.0021 | 32617772 |
| ABCG2 | 74 | LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by RT-PCR | NA | 0.2 | 0.1739 | 21455326 |
| BMI1 | 1066 | LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | RT-PCR followed by SFA | NA | 0.2 | 0.1135 | 23674142 |
| POU5F1 | 9221 | LTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | RT-PCR followed by SFA | NA | 0.2 | 0.6448 | 23674142 |
| MIR101-1 | 31488 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 22180714 |
| MIR1202 | 35268 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 23007737 |
| MIR1229 | 33924 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23007737 |
| MIR1234 | 33926 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 23007737 |
| MIR1265 | 35332 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23007737 |
| MIR1285-1 | 35277 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23007737 |
| MIR1287 | 35280 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23007737 |
| MIR138-2 | 31525 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 22180714 |
| MIR17 | 31547 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 22180714 |
| MIR193A | 31563 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 22180714 |
| MIR197 | 31569 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23007737 |
| MIR1972-1 | 37060 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23007737 |
| MIR1976 | 37064 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23007737 |
| MIR19A | 31574 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 22180714 |
| MIR20A | 31577 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 22180714 |
| MIR210 | 31587 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0064 | 23007737 |
| MIR2114 | 37308 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23007737 |
| MIR2116 | 37310 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23007737 |
| MIR221 | 31601 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 23007737 |
| MIR222 | 31602 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 23007737 |
| MIR23A | 31605 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 22180714 |
| MIR29A | 31616 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 23007737 |
| MIR29C | 31621 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 22180714 |
| MIR301A | 31622 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 22180714 |
| MIR30e | 31629 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 22180714 |
| MIR31 | 31630 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 22180714 |
| MIR31 | 31630 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 23007737 |
| MIR3135B | 41783 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23007737 |
| MIR3145 | 38327 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23007737 |
| MIR3149 | 38251 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23007737 |
| MIR3150B | 38938 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23007737 |
| MIR3197 | 38366 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23007737 |
| MIR365A | 33692 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 23007737 |
| MIR3679 | 38979 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23007737 |
| MIR374A | 31788 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 22180714 |
| MIR424 | 31881 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 22180714 |
| MIR4253 | 38231 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23007737 |
| MIR4254 | 38193 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23007737 |
| MIR4259 | 38309 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23007737 |
| MIR4323 | 38394 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23007737 |
| MIR4428 | 41667 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 23007737 |
| MIR4448 | 41604 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23007737 |
| MIR4451 | 41858 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23007737 |
| MIR4487 | 41851 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 23007737 |
| MIR449B | 32794 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 23007737 |
| MIR4521 | 41813 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 23007737 |
| MIR4524A | 41771 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23007737 |
| MIR4651 | 41647 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23007737 |
| MIR4688 | 41897 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 23007737 |
| MIR4701 | 41627 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23007737 |
| MIR4722 | 41782 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23007737 |
| MIR4725 | 41608 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23007737 |
| MIR4728 | 41632 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23007737 |
| MIR4741 | 41661 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 23007737 |
| MIR4763 | 41677 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23007737 |
| MIR4769 | 41694 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23007737 |
| MIR4784 | 41580 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23007737 |
| MIR486-1 | 32342 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0053 | 23007737 |
| MIR487B | 32533 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 22180714 |
| MIR493 | 32082 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 22180714 |
| MIR497 | 32088 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 22180714 |
| MIR519A1 | 32128 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 22180714 |
| MIR522 | 32127 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 22180714 |
| MIR524 | 32110 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 22180714 |
| MIR542 | 32534 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 22180714 |
| MIR561 | 32817 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 22180714 |
| MIR574 | 32830 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 23007737 |
| MIR582 | 32838 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0064 | 22180714 |
| MIR584 | 32840 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 22180714 |
| MIR590 | 32846 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 22180714 |
| MIR7-1 | 31638 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0042 | 23007737 |
| MIR766 | 33139 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 23007737 |
| MIR874 | 33643 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0021 | 22180714 |
| MIR876 | 33653 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 22180714 |
| MIR877 | 33660 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 23007737 |
| MIR877 | 33660 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23007737 |
| MIR885 | 33659 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0011 | 23007737 |
| MIR96 | 31648 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Up | 0.04 | 0.0032 | 22180714 |
| VTRNA2-1 | 37054 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 22180714 |
| VTRNA2-1 | 37054 | HTM | Dukes Type A Colon Cancer | Adenocarcinoma | SW1116 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 22180714 |